New methods to assess the effects of tobacco product regulations
Innovative Statistical Methods for Estimating the Impact of Tobacco Product Standards
This study is looking at how new rules about lowering nicotine in tobacco products can affect people's health and help them quit smoking, so we can find better ways to support everyone trying to kick the habit.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11084128 on NIH RePORTER |
What this research studies
This research focuses on developing innovative statistical methods to evaluate the impact of tobacco product standards, particularly those aimed at reducing nicotine levels. By analyzing both the direct effects and unintended consequences of these regulations, the research aims to provide a comprehensive understanding of how such standards can influence public health. The approach includes rigorous study designs and data integration to ensure accurate estimations of the impact on smoking cessation and population health. Patients may benefit from insights that could lead to more effective tobacco control policies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who smoke or are affected by tobacco use and are interested in cessation or the effects of tobacco regulations.
Not a fit: Patients who do not use tobacco products or are not affected by tobacco-related health issues may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective tobacco regulations that improve public health and support smoking cessation efforts.
How similar studies have performed: Previous research has shown success in using innovative statistical methods to evaluate tobacco regulations, indicating a promising approach for this study.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Koopmeiners, Joseph S. — University of Minnesota
- Study coordinator: Koopmeiners, Joseph S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.